Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sinemet in Neovascular AMD
NCT03022318Phase 2Completed
- Sponsor
- Robert W. Snyder
- Start
- May 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levodopa in neovascular age-related macular degeneration (NVAMD), sponsored by Robert W. Snyder. Started May 2017; status: completed.
02
Drugs
levodopa
03
Conditions
neovascular age-related macular degeneration (NVAMD)
Beyond the preview
Go deeper on NCT03022318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03022318.